The Role of Inhaled Corticosteroids in Reducing Cardiovascular Risk: Seeing Is Not Always Believing.
作者信息
Quint Jennifer K
机构信息
School of Public Health Imperial College London London, United Kingdom.
出版信息
Am J Respir Crit Care Med. 2025 Feb;211(2):142-143. doi: 10.1164/rccm.202407-1494ED.
Abstract
摘要
相似文献
1
The Role of Inhaled Corticosteroids in Reducing Cardiovascular Risk: Seeing Is Not Always Believing.吸入性糖皮质激素在降低心血管风险中的作用：眼见未必为实。
Am J Respir Crit Care Med. 2025 Feb;211(2):142-143. doi: 10.1164/rccm.202407-1494ED.
2
Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults and children.对于未使用过类固醇的成人和儿童持续性哮喘，吸入长效β2受体激动剂联合吸入性类固醇作为一线治疗方案。
Cochrane Database Syst Rev. 2009 Oct 7;2009(4):CD005307. doi: 10.1002/14651858.CD005307.pub2.
3
Inhaled corticosteroids for cystic fibrosis.用于囊性纤维化的吸入性糖皮质激素。
Cochrane Database Syst Rev. 2014 Oct 9(10):CD001915. doi: 10.1002/14651858.CD001915.pub4.
4
Inhaled corticosteroids for cystic fibrosis.用于囊性纤维化的吸入性糖皮质激素。
Cochrane Database Syst Rev. 2016 Aug 23(8):CD001915. doi: 10.1002/14651858.CD001915.pub5.
5
Seeing/believing/seeing: perception-correcting and cognitive skills.眼见/相信/眼见：感知矫正与认知技能。
Soc Work. 1991 May;36(3):243-6.
6
Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma.在患有持续性哮喘的成人和儿童中，长效β2受体激动剂与高剂量吸入性类固醇联合使用与单纯使用高剂量吸入性类固醇的比较。
Cochrane Database Syst Rev. 2010 Apr 14(4):CD005533. doi: 10.1002/14651858.CD005533.pub2.
7
Inhaled corticosteroids for cystic fibrosis.用于囊性纤维化的吸入性皮质类固醇。
Cochrane Database Syst Rev. 2019 Jul 4;7(7):CD001915. doi: 10.1002/14651858.CD001915.pub6.
8
Inhaled corticosteroids do not affect the antibody titer against the SARS-CoV-2 spike protein in BNT162b2 mRNA vaccinated patients.吸入性皮质类固醇对接种BNT162b2 mRNA疫苗的患者体内针对SARS-CoV-2刺突蛋白的抗体滴度没有影响。
Allergy Asthma Clin Immunol. 2022 Aug 25;18(1):78. doi: 10.1186/s13223-022-00719-6.
9
Local and systemic adverse effects of inhaled corticosteroids - Does ciclesonide differ from other inhaled corticosteroids?
Respir Med. 2025 Mar;238:107962. doi: 10.1016/j.rmed.2025.107962. Epub 2025 Feb 5.
10
Seeing is believing--or is believing seeing?眼见为实——还是相信即所见？
J Psychosoc Nurs Ment Health Serv. 2002 Jan;40(1):9-10. doi: 10.3928/0279-3695-20020101-03.
本文引用的文献
1
Effect of Triple Therapy on Cardiovascular and Severe Cardiopulmonary Events in Chronic Obstructive Pulmonary Disease: A Analysis of a Randomized, Double-Blind, Phase 3 Clinical Trial (ETHOS).三联疗法对慢性阻塞性肺疾病心血管及严重心肺事件的影响：一项随机、双盲、3期临床试验（ETHOS）分析
Am J Respir Crit Care Med. 2025 Feb;211(2):205-214. doi: 10.1164/rccm.202312-2311OC.
2
Long-term inhaled corticosteroid treatment in patients with chronic obstructive pulmonary disease, cardiovascular disease, and a recent hospitalised exacerbation: The ICSLIFE pragmatic, randomised controlled study.慢性阻塞性肺疾病、心血管疾病和近期住院加重的患者中长期吸入皮质类固醇治疗：ICS-LIFE 实用、随机对照研究。
Eur J Intern Med. 2024 Oct;128:104-111. doi: 10.1016/j.ejim.2024.07.001. Epub 2024 Jul 8.
3
New risk score for cardiovascular disease with improved performance.性能得到改善的心血管疾病新风险评分。
Nat Med. 2024 May;30(5):1255-1256. doi: 10.1038/s41591-024-02906-x.
4
Temporal Risk of Nonfatal Cardiovascular Events After Chronic Obstructive Pulmonary Disease Exacerbation: A Population-based Study.慢性阻塞性肺疾病急性加重后非致命性心血管事件的时间风险：一项基于人群的研究。
Am J Respir Crit Care Med. 2024 Apr 15;209(8):960-972. doi: 10.1164/rccm.202307-1122OC.
5
Cause-specific mortality in COPD subpopulations: a cohort study of 339 647 people in England.COPD 亚人群的病因特异性死亡率：一项对英格兰 339647 人的队列研究。
Thorax. 2024 Feb 15;79(3):202-208. doi: 10.1136/thorax-2022-219320.
6
Inhaled Corticosteroids and Risk of Cardiovascular Disease in Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Regression.吸入性糖皮质激素与慢性阻塞性肺疾病患者的心血管疾病风险：一项系统评价和Meta回归分析
Chronic Obstr Pulm Dis. 2023 Jul 26;10(3):317-327. doi: 10.15326/jcopdf.2022.0386.
7
Association of Inhaled Corticosteroids With All-Cause Mortality Risk in Patients With COPD: A Meta-analysis of 60 Randomized Controlled Trials.吸入皮质类固醇与 COPD 患者全因死亡率的相关性：60 项随机对照试验的荟萃分析。
Chest. 2023 Jan;163(1):100-114. doi: 10.1016/j.chest.2022.07.015. Epub 2022 Jul 31.
8
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2022年美国心脏协会/美国心脏病学会/美国心力衰竭学会心力衰竭管理指南：执行摘要：美国心脏病学会/美国心脏协会临床实践指南联合委员会报告
J Am Coll Cardiol. 2022 May 3;79(17):1757-1780. doi: 10.1016/j.jacc.2021.12.011. Epub 2022 Apr 1.
9
Relationship between heart failure and the risk of acute exacerbation of COPD.心力衰竭与慢性阻塞性肺疾病急性加重风险之间的关系。
Thorax. 2021 Apr 29;76(8):807-14. doi: 10.1136/thoraxjnl-2020-216390.
10
Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease: Benefits and Risks.慢性阻塞性肺疾病中的吸入性皮质类固醇：获益与风险。
Clin Chest Med. 2020 Sep;41(3):475-484. doi: 10.1016/j.ccm.2020.05.006.
Zotero 插件